Blogs

Latest Blogs

[wd_asp id=2]

Antibody‑Drug Conjugates (ADCs): The Tipping Point

May 28, 2026

The field of antibody-drug conjugates (ADCs) is entering an exciting era, and there is no shortage of writing today about where this modality is headed:…

Synexa raises awareness for Rare Diseases Day

February 28, 2022

28 February 2022 marks Rare Disease Awareness Day and here at Synexa Life Sciences we are sharing our colours to…

Behind The Wave: The Importance of Post-Market Surveillance and its Pertinence to the COVID-19 Pandemic

May 20, 2021

The world has become engrossed in the vaccine development process since the world’s researchers began their race to provide a…

The Biomarker Association between Depression and Vascular Disease

February 15, 2021

Major depressive disorder (MDD) has repeatedly emerged as a confounding or prognostic factor in the development of cardiovascular pathologies and…

Infertility and the importance of the endometrial immune balance

February 15, 2021

Infertility is defined by the World Health Organisation as the inability of a sexually active non-contracepting couple, to conceive after…

Immunogenicity 101: Antidrug Antibodies, Neutralising Antibodies, and everything in between

January 20, 2021

Protein-based biotherapeutic/biologic agents, such as fusion proteins and monoclonal antibodies (mAb) have become the treatment of choice for many indications…

Th17 Cells and IL-17: a possible link between inflammation and neuronal decline in Multiple Sclerosis

September 18, 2020

Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease of the central nervous system (CNS). A major component of the…